160 related articles for article (PubMed ID: 17707480)
21. Meningioma mimicking puerperal psychosis.
Khong SY; Leach J; Greenwood C
Obstet Gynecol; 2007 Feb; 109(2 Pt2):515-6. PubMed ID: 17267878
[TBL] [Abstract][Full Text] [Related]
22. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.
Maiuri F; De Caro MB; Esposito F; Cappabianca P; Strazzullo V; Pettinato G; de Divitiis E
J Neurooncol; 2007 Mar; 82(1):63-8. PubMed ID: 17225937
[TBL] [Abstract][Full Text] [Related]
23. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
Monleón D; Morales JM; Gonzalez-Darder J; Talamantes F; Cortés O; Gil-Benso R; López-Ginés C; Cerdá-Nicolás M; Celda B
J Proteome Res; 2008 Jul; 7(7):2882-8. PubMed ID: 18507434
[TBL] [Abstract][Full Text] [Related]
24. CD44 expression in human meningiomas: an immunohistochemical analysis.
Lewy-Trenda I; Omulecka A; Janczukowicz J; Papierz W
Pol J Pathol; 2004; 55(1):33-7. PubMed ID: 15195704
[TBL] [Abstract][Full Text] [Related]
25. Intracranial papillary meningioma: a clinicopathologic study of 30 cases at a single institution.
Wang XQ; Chen H; Zhao L; Li ST; Hu J; Mei GH; Jiang CC
Neurosurgery; 2013 Nov; 73(5):777-90; discussion 789. PubMed ID: 23921710
[TBL] [Abstract][Full Text] [Related]
26. Pathology quiz case 2. Atypical meningioma with clear cell features (World Health Organization [WHO] grade II).
Brenner MJ; Perrin RJ; Uppaluri R; Zipfel GJ; Lewis JS
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):447-9. PubMed ID: 18427017
[No Abstract] [Full Text] [Related]
27. CD90 expression in atypical meningiomas and meningioma metastasis.
Scognamiglio G; D'Antonio A; Rossi G; Cavazza A; Camerlingo R; Pirozzi G; La Mantia E; Anniciello AM; Morabito A; Cantile M; Boscaino A; Sparano L; Botti G; Rocco G; Franco R
Am J Clin Pathol; 2014 Jun; 141(6):841-9. PubMed ID: 24838329
[TBL] [Abstract][Full Text] [Related]
28. Sclerosing meningioma: immunohistochemical analysis of five cases.
Kim NR; Im SH; Chung CK; Suh YL; Choe G; Chi JG
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):126-35. PubMed ID: 15043710
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.
Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M
Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of clinical and pathological features of secretory meningiomas].
Li XJ; Zhang HY; Lang ZQ; Wei B; Chen HJ; Bu H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):488-91. PubMed ID: 16761441
[TBL] [Abstract][Full Text] [Related]
31. Automated nuclear segmentation in the determination of the Ki-67 labeling index in meningiomas.
Kim YJ; Romeike BF; Uszkoreit J; Feiden W
Clin Neuropathol; 2006; 25(2):67-73. PubMed ID: 16550739
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 immunoreactivity in meningiomas.
Milenković S; Marinkovic T; Jovanovic MB; Djuricic S; Berisavac II; Berisavac I
Cell Mol Neurobiol; 2008 Sep; 28(6):907-13. PubMed ID: 18379871
[TBL] [Abstract][Full Text] [Related]
33. Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas.
Barresi V; Cerasoli S; Tuccari G
Neuropathology; 2008 Oct; 28(5):472-8. PubMed ID: 18282163
[TBL] [Abstract][Full Text] [Related]
34. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining.
Ferraraccio F; Accardo M; Giangaspero F; Cuccurullo L
Clin Neuropathol; 2003; 22(4):187-92. PubMed ID: 12908755
[TBL] [Abstract][Full Text] [Related]
35. Biochemical, histochemical and immunohistochemical study of glycosaminoglycans in human meningiomas.
Bertolotto A; Giordana MT; Orsi L; Orsi R; Schiffer D
Basic Appl Histochem; 1989; 33(3):239-49. PubMed ID: 2818425
[TBL] [Abstract][Full Text] [Related]
36. [The features of pathology and immunohistochemistry in orbital meningiomas].
Hei Y; Zhang XW; Wang Y; Lu XZ; Yang XJ; Xiao LH
Zhonghua Yan Ke Za Zhi; 2006 Nov; 42(11):998-1001. PubMed ID: 17386138
[TBL] [Abstract][Full Text] [Related]
37. Progesterone receptor expression and Ki-67 labelling index of meningiomas in the Lagos university teaching hospital.
Ikeri NZ; Anunobi CC; Bankole OB
Niger Postgrad Med J; 2018; 25(1):17-20. PubMed ID: 29676340
[TBL] [Abstract][Full Text] [Related]
38. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
Faratian D; Munro A; Twelves C; Bartlett JM
Histopathology; 2009 Jan; 54(2):254-7. PubMed ID: 19207951
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
Suthipintawong C; Wejaranayang C; Vipupinyo C
J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in canine and feline meningioma.
Mandara MT; Pavone S; Mandrioli L; Bettini G; Falzone C; Baroni M
Vet Pathol; 2009 Sep; 46(5):836-45. PubMed ID: 19276056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
